At Emerging Markets, we like to keep our eye on new potentially disruptive sectors. We found Cannabis in 2010 and everyone laughed at us. Fast forward to today Cannabis has turned into a massive industry. We see psychedelics as the next Cannabis. Peter Thiel has backed several companies in this space, as the saying goes "follow the money". Enter SILO, a company new to market who has assembled a very impressive team. As the saying goes, "bet on the jockey"
Silicon Valley Billionaire Peter Thiel Backs Psychedelics Firm ATAI in $24 Million Funding Round
Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson's, and other rare neurological disorders. Silo's mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry.
Held at DTC
Market Value calculated only for respective security
Emerging Markets Consulting LLC has been paid 35,000 dollars by SILO Pharma. EMC is contracted to receive an additional 35,000 dollars. https://www.emergingmarketsllc.com/disclaimer/